Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.5K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the editor: Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross-sectional study.

Journal of diabetes investigation·2026
Same author

PPa1 insufficiency drives lysosomal storage disease and inflammatory macrophage expansion in the bone marrow.

bioRxiv : the preprint server for biology·2026
Same author

'Tripod-like' lung-targeting (LuT) lipids for highly efficient and selective LNPs for gene delivery and editing.

Nature biomedical engineering·2026
Same author

MEK inhibitor mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.

The Journal of clinical investigation·2026
Same author

<i>Hilnc-</i>mediated UCP1 translation repression contributes to thermogenesis and energy expenditure.

Theranostics·2026
Same author

Paclitaxel- Versus Sirolimus-Coated Balloons in Percutaneous Coronary Intervention for Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.

Cardiology in review·2026

Related Experiment Video

Updated: Jun 16, 2025

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K

KBTBD2 controls bone development by regulating IGF-1 signaling during osteoblast differentiation.

Yu Xun1,2, Yiao Jiang1,2, Aysha Khalid3

  • 1Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Cell Death and Differentiation
|November 20, 2024
PubMed
Summary

Kelch repeat and BTB domain-containing 2 (KBTBD2) is crucial for bone formation by regulating the IGF-1/AKT pathway. Its dysfunction is linked to SHORT syndrome, a growth disorder.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.4K
Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

13.9K

Related Experiment Videos

Last Updated: Jun 16, 2025

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.4K
Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

13.9K

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Skeletal Biology

Background:

  • Kelch repeat and BTB (POZ) domain-containing 2 (KBTBD2) is recognized for its role in metabolic regulation within adipocytes.
  • The specific function of KBTBD2 in skeletal development and bone formation has not been previously elucidated.

Purpose of the Study:

  • To investigate the role of KBTBD2 in skeletal development and bone formation.
  • To elucidate the molecular mechanisms by which KBTBD2 influences osteogenesis.
  • To explore the connection between KBTBD2, the IGF-1 signaling pathway, and SHORT syndrome.

Main Methods:

  • Conditional knockout of Kbtbd2 in embryonic osteochondroprogenitor cells and osteoblasts.
  • Analysis of osteogenic differentiation, skeletal growth, and mineralization.
  • Investigation of protein interactions and signaling pathway activation (AKT, IGF-1).
  • Study of a specific p85α mutation (p.(Arg649Trp)) found in SHORT syndrome patients.

Main Results:

  • Kbtbd2 deficiency in osteogenic cells impairs differentiation, leading to reduced skeletal growth and mineralization.
  • Loss of KBTBD2 results in p85α accumulation, inhibiting IGF-1-induced AKT activation.
  • A common SHORT syndrome mutation in p85α reduces its binding to KBTBD2, impairing IGF-1 signaling.

Conclusions:

  • KBTBD2 is essential for bone formation through its regulation of the IGF-1 signaling pathway.
  • Impaired KBTBD2-mediated regulation of p85α is a potential mechanism underlying SHORT syndrome.
  • This study highlights KBTBD2 as a key player in both metabolic regulation and skeletal development.